Pharmafile Logo

News and Press Releases

Infant Bacterial Therapeutics AB secures partnership with Recipharm Advanced Bio for commercial production of drug substance

IBP-9414 targets mortality and gastrointestinal injury in premature infants With Breakthrough Therapy designation for gastro-intestinal mortality and Rare Paediatric Disease designations, IBP-9414 is on an accelerated path to commercialisation   PPQ...

Category: BioManufacturing, Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: December 1, 2025

Recipharm

Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support

Telomir-1 has now entered GMP preparation, and Ketamir-2 has completed the Phase 1 SAD stage, reflecting steady advancement of both programmes These milestones mark tangible progress in development and demonstrate...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 26, 2025

Recipharm

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three...

Category: BioManufacturing, Drug Delivery, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 15, 2025

University of Oxford and ReciBioPharm expand strategic collaboration in fight against malaria

Expands the collaboration to manufacture two malaria vaccine candidates (R78C and RH5.1) for Phase 1/2 clinical trials Delivers the sixth malaria vaccine candidate for the University of Oxford Provides drug...

Category: Biotechnology, Clinical Trials, Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 9, 2025

Recipharm

Spektus Pharma and Recipharm Announce Strategic Partnership to Develop and Supply CNS Medicines Using Flexitab™ Oral Drug Delivery Platform

22 January 2025 -- Montreal, Canada -- Spektus Pharma, an innovator in value added medicine development, and Recipharm, a leading global contract development and manufacturing organization, have entered into a...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 22, 2025

Recipharm

Recipharm attains major sustainability milestones

Approval of ambitious Greenhouse Gas emission reduction targets by SBTi Commitment to renewable electricity sourcing to 100.0% by 2024 and to 42.1% GHG emission reduction (Scope 1 and 2) by...

Category: Manufacturing and Packing
Posted: March 26, 2024

Recipharm

Recipharm, Medspray and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology

Partnership will help bring breakthroughs in the nasal delivery of fragile biologics and small molecules to market 23 January 2023 -- Stockholm, Sweden -- Recipharm, a leading contract development and...

Category: Drug Delivery
Posted: January 23, 2024

Recipharm